Aidaptus disposable autoinjector. (Credit: Owen Mumford)

Owen Mumford has been awarded a distinction in the prestigious Red Dot awards for innovative product design for its Aidaptus single-use auto-injector, which the company launched in 2021. Aidaptus won the Red Dot award for the category Product Design 2023.

Aidaptus is a single-use autoinjector created for the administration of a wide range of drugs and biologics that require subcutaneous delivery. Aidaptus features distinctive design elements that benefit both drug companies and patients, which the company says helped it secure the award. The unique auto adjust stopper-sensing technology features a self-adjusting plunger that automatically adapts to different fill volumes in each syringe, with no change parts required.

“Our Aidaptus auto-injector platform has been designed to reduce complexity and provide a flexible solution for pharmaceutical and biotechnology companies who are developing a variety of drug formulations for subcutaneous delivery. It tackles the challenges of changes to drug formulation or injected volume and can therefore help reduce risk during drug development and lifecycle management,” said Michael Earl, Director, Owen Mumford Pharmaceutical Services. “In addition, Aidaptus will help patients to self-administer their individual therapies for diseases such as rheumatoid arthritis, Crohn’s disease and multiple sclerosis, using a simple and easy to use device.”

The versatile design also accommodates both 1 and 2.25 mL prefilled glass syringes in the same compact base device. This provides pharmaceutical companies with a single solution for delivery of a variety of drug formulations. In addition, the compact design and simple two-step injection process provides ease of use and confidence for those patients who require subcutaneous medication. The intuitive design is key to helping patients administer their own treatments in a home setting, helping to reduce the burden on healthcare practitioners and services.

“Red Dot is one of the most prestigious design competitions that is highly competitive, and we are honored to be globally recognized with distinction in the Product Design 2023 category,” says Jarl Severn, CEO of Owen Mumford. “We have previously enjoyed this accolade for our Unifine® Pentips® Plus pen needle and today’s news further underscores our ongoing pursuit and commitment to excellence in design.”

Aidaptus will be manufactured in state-of-the art factories in Malaysia and the new Owen Mumford production facility in Witney, UK, which is due for completion later this year. The site is being developed in accordance with BREEAM guidelines, recognizing the highest levels of environmental, social, and economic sustainability performance. The new center of excellence will play an important role in supporting the core principles of the organization — doing business in a responsible and ethical way. In addition, Owen Mumford is collaborating with Stevanato Group for molding and assembly of Aidaptus which gives customers the benefit of dual sourcing and security of supply, the company says.